Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Goding lab, working in collaboration with the University Rey Juan Carlos, have shown that fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma invasiveness.

Scientists in a lab

Cancer progression and non-genetic therapy resistance are driven by interactions between the tumour microenvironment and cancer cell plasticity. Phenotype-specific expression of the AXL receptor tyrosine kinase is key in cancer invasion and resistance to treatment, but how the ALX is activated has remained unclear.

Using melanoma as a model, the Goding research group and collaborators at University Rey Juan Carlos show that AXL is activated by exposure to human adipocytes and to oleic acid, a fatty acid abundant in lymph and adipocytes. The activation of AXL triggers formation and translocation of a β-catenin-CAV1 complex required for melanoma invasiveness.

Of particular note, only undifferentiated, high in AXL melanoma cells engage in symbiosis with human adipocytes, leading to AXL-dependent fatty acid uptake and nuclear localisation of the β-catenin-CAV1 complex. These results demonstrate an AXL and CAV-1 dependent mechanism by which a nutritional input drives phenotype-specific activation of a pro-metastasis program.

Given the key role of AXL in a wide range of cancers, the results offer major insights into the mechanisms of cancer cell dormancy and therapy resistance.

Professor Colin Goding, Professor of Oncology at Ludwig Cancer Research, said: ‘In melanoma, and many other cancers, cancer cells adopt different states depending on their environment.  Especially important are those that stop dividing and become invasive, leading to metastasis and resistance to drug and immunotherapies. One key gene encoding the AXL receptor has been linked to invasion and therapy resistance in many cancers, but how AXL might be activated as cell leave the primary tumor was unclear. This work revealed that invasive, but not proliferative melanoma cells, induce fatty acid release from adipocytes, and that oleic acid, a common fatty acid found in adipocytes and lymph, can activate AXL. The findings provide a major insight into phenotype-specific interactions with the microenvironment, and novel opportunities for therapeutic intervention.’

Read the full paper on the Genes & Development website: https://genesdev.cshlp.org/content/early/2025/02/27/gad.351985.124.full.pdf+html

Similar stories

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

A New Layer of Control for a Decades-Old Leukemia Drug

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led jointly by researchers from CeMM and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body’s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

New study improves early detection of life threatening infection in children across South and South East Asia

A new study published in Nature Medicine suggests that simple, low-cost tools could help health workers identify children at risk of life-threatening infection earlier, improving access to urgent care in across South and South East Asia.